Search research articles
Contact Us
Filters
Showing results (321-330 of 574) with videos related to
Page
of 58
Sort By:
Clinical Lung Cancer
|
February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors
Sally C M Lau, Aline Fusco Fares, Lisa W Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
Pooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2025
Taletrectinib in <i>ROS1</i>+ Non-Small Cell Lung Cancer: TRUST
Maurice Pérol, Wei Li, Nathan A Pennell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2011
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer
Linda E Coate, Christine Massey, Andrew Hope, et al.
Gynecologic Oncology
|
March 15, 2015
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
Ivan Diaz-Padilla, Michelle K Wilson, Blaise A Clarke, et al.
The Oncologist
|
April 3, 2019
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer
Anuradha Vasista, Martin Stockler, Andrew Martin, et al.
Iscience
|
November 25, 2022
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction
Sami Ul Haq, Sabine Schmid, Mansi K Aparnathi, et al.
International Journal of Cancer
|
September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Heliyon
|
September 19, 2024
Outcomes with non-small cell lung cancer and brain-only metastasis
Sabine Schmid, Miguel Garcia, Luna Zhan, et al.
International Journal of Cardiology
|
May 1, 2018
Understanding the patient perspective on research access to national health records databases for conduct of randomized registry trials
Robert Avram, Guillaume Marquis-Gravel, François Simard, et al.
Page
of 58
Search research articles
Search
Showing results (321-330 of 574) with videos related to
Sort By:
Page
of 58
Clinical Lung Cancer
|
February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors
Sally C M Lau, Aline Fusco Fares, Lisa W Le, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
Pooja Middha, Rohit Thummalapalli, Zoe Quandt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2025
Taletrectinib in <i>ROS1</i>+ Non-Small Cell Lung Cancer: TRUST
Maurice Pérol, Wei Li, Nathan A Pennell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 25, 2011
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer
Linda E Coate, Christine Massey, Andrew Hope, et al.
Gynecologic Oncology
|
March 15, 2015
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
Ivan Diaz-Padilla, Michelle K Wilson, Blaise A Clarke, et al.
The Oncologist
|
April 3, 2019
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer
Anuradha Vasista, Martin Stockler, Andrew Martin, et al.
Iscience
|
November 25, 2022
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction
Sami Ul Haq, Sabine Schmid, Mansi K Aparnathi, et al.
International Journal of Cancer
|
September 16, 2021
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Heliyon
|
September 19, 2024
Outcomes with non-small cell lung cancer and brain-only metastasis
Sabine Schmid, Miguel Garcia, Luna Zhan, et al.
International Journal of Cardiology
|
May 1, 2018
Understanding the patient perspective on research access to national health records databases for conduct of randomized registry trials
Robert Avram, Guillaume Marquis-Gravel, François Simard, et al.
Page
of 58